Day: November 27, 2023

Nine Mile Metals Updates Loan Financing to Convertible Loan

Nine Mile Metals Updates Loan Financing to Convertible Loan

VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it will update the proposed unsecured loan financing for proceeds of up to $500,000 that it announced in the Company’s news release on November 21, 2023, to an unsecured convertible loan financing (the “Convertible Loan”). The Convertible Loan financing will be for proceeds of up to $500,000. The Convertible Loans will have a term of 12 months from the closing (the “Maturity Date”) and bear interest at 15 per cent per annum, calculated and payable on the Maturity Date. Convertible Loan proceeds will be used for advancing the bulk sample program on the Nine Mile Brook project and general working capital. No bonus shares will be offered in connection with the Convertible...

Continue reading

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

– Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life – – SpringWorks to host conference call tomorrow at 8:00 a.m. ET – A Media Snippet accompanying this announcement is available by clicking on this link. STAMFORD, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the U.S. Food and Drug Administration (FDA) has approved OGSIVEO™ (nirogacestat), an oral gamma secretase inhibitor, for the treatment of adult patients with progressing desmoid tumors who require systemic treatment.1 The...

Continue reading

NorthWest Copper Corp. Announces Launch of Rights Offering and Concurrent Private Placement

NorthWest Copper Corp. Announces Launch of Rights Offering and Concurrent Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) — NorthWest Copper Corp. (the “Company” or “NorthWest”) (TSX-V: NWST) announces it is undertaking a rights offering to raise gross proceeds of up to $3,340,936 (the “Rights Offering”) and private placements to bring the total amount raised by the Company to no more than $4,000,000 (“Concurrent Private Placement”). Rights Offering Pursuant to the Rights Offering, the Company will be offering 31,818,435 rights (the “Rights”) to holders (the “Shareholders) of common shares in the capital of NorthWest (the “NorthWest Shares”) at the close of business on the record date of December 5, 2023 (the “Record Date”) on the basis of one (1) Right for each six (6) NorthWest Shares held....

Continue reading

First Busey Corporation and Merchants and Manufacturers Bank Corporation to Merge

First Busey Corporation and Merchants and Manufacturers Bank Corporation to Merge

First Busey Expands Market Presence in Chicago MSA and Adds Life Equity Loan® Products to Suite of Services CHAMPAIGN, Ill. and OAKBROOK TERRACE, Ill., Nov. 27, 2023 (GLOBE NEWSWIRE) — First Busey Corporation (“Busey”) (NASDAQ:BUSE), the holding company for Busey Bank, and Merchants and Manufacturers Bank Corporation (”M&M”), the holding company for Merchants & Manufacturers Bank (“M&M Bank”), today jointly announced the signing of a definitive agreement pursuant to which Busey will acquire M&M Bank through a merger transaction. The partnership will enhance Busey’s growing suburban Chicago market presence by expanding the company’s deposit market share in DuPage and Will Counties, while bolstering its commercial banking relationships and wealth management capabilities. Under the terms of the merger agreement,...

Continue reading

Brookfield Corporation Announces Pricing of $700 Million Notes Offering

Brookfield Corporation Announces Pricing of $700 Million Notes Offering

BROOKFIELD, NEWS, Nov. 27, 2023 (GLOBE NEWSWIRE) — Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced the pricing of a public offering of $700 million principal amount of senior notes due 2034 (the “notes”), which will bear interest at a rate of 6.350% per annum. The net proceeds from the sale of the notes will be used to refinance existing indebtedness, including upcoming 2024 maturities, and will leave only modest maturities through to the end of 2025.  The notes will be issued by Brookfield Finance Inc., an indirect 100% owned subsidiary of Brookfield, and will be fully and unconditionally guaranteed by Brookfield. The offering is expected to close on or about December 4, 2023, subject to the satisfaction of customary closing conditions. The notes are being offered under Brookfield and the issuer’s existing...

Continue reading

iBio Announces Reverse Stock Split

iBio Announces Reverse Stock Split

BRYAN, Texas and SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) today announced that its Board of Directors has approved a 20-to-1 reverse split of the Company’s common stock, par value $0.001 per share (the “Common Stock”) effective at 12:01 a.m. ET on November 29, 2023 (the “Effective Date”). The Common Stock is expected to begin trading on a split-adjusted basis when the market opens on November 29, 2023, with the new CUSIP number 451033708.    The reverse stock split was authorized by iBio’s stockholders at the Company’s 2023 Annual Meeting, held earlier today, with a ratio ranging from 1-for-5 to 1-for-20 (the “Range”), with the ration within such Range to be determined at the discretion of the Company’s Board of Directors. As a result of the reverse stock split, every 20 shares...

Continue reading

Calian Reports Unaudited Results for the Fourth Quarter and FY23

Calian Reports Unaudited Results for the Fourth Quarter and FY23

(All amounts in release are in Canadian dollars) OTTAWA, Nov. 27, 2023 (GLOBE NEWSWIRE) — Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, today released its unaudited results for the fourth quarter and FY23 ended September 30, 2023. Highlights of record performance in Q4: Revenue up 10% to $176 million Gross margin at 31.7%, above 30% for the sixth consecutive quarter Adjusted EBITDA1 at $20 million, up 7% Highlights of FY23: Revenue up 13% to $659 million Gross margin at 31.0%, up from 29.1% last year Adjusted EBITDA1 at $66 million, in line with last year Operating free cash flow of $45 million Net liquidity of $176 million Repurchased 32,094 shares for consideration of $1.7 million Acquired Hawaii Pacific Teleport...

Continue reading

Microchip Technology to Present at the UBS Technology Conference

Microchip Technology to Present at the UBS Technology Conference

CHANDLER, Ariz., Nov. 27, 2023 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the UBS Technology Conference on Tuesday, November 28 at 9:35 a.m. (Mountain Time). Presenting for the Company will be Mr. Ganesh Moorthy, President and CEO. A live webcast of the presentation will be made available by UBS, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC’s website (www.sec.gov) or from commercial document retrieval...

Continue reading

Consolidated Uranium and Premier American Uranium Announce Closing of Spin-Out

Consolidated Uranium and Premier American Uranium Announce Closing of Spin-Out

TORONTO, Nov. 27, 2023 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR”, the “Company”, or “Consolidated Uranium”) (TSXV: CUR) (OTCQX: CURUF) and Premier American Uranium Inc. (“PUR” or “Premier American Uranium”) are pleased to announce that the previously announced spin-out of PUR through a plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement”) has been completed. The Arrangement was effective at 12:01 a.m. (Toronto time) on November 27, 2023. Pursuant to the Arrangement, CUR transferred ownership of certain indirect wholly-owned subsidiaries that hold eight U.S. Department of Energy (“DOE”) leases and certain patented claims located in Colorado (the “CUR Assets”) to PUR in exchange for 7,753,752 common shares of PUR (“PUR Shares”). As part of the Arrangement, CUR distributed 3,876,786 of the...

Continue reading

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requirements BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada corporation (the “Buyer”), an entity affiliated with current GVB employees. The transaction is subject to certain approvals and Buyer obtaining financing. Terms of the transaction include a cash payment to the Company of $1 million at closing of the sale (the “Closing”) and a 12% secured promissory note for $1.25 million issued...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.